Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of genistein administration on the recovery of spermatogenesis in the busulfan-treated rat testis

  • Received : 2013.04.09
  • Accepted : 2013.05.21
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Impairment of spermatogenesis has been identified as an inevitable side effect of cancer treatment. Although estrogen treatment stimulates spermatogenic recovery from the impaired spermatogenesis by suppressing the intra-testicular testosterone (ITT) level, side effects of estrogen are still major impediments to its clinical application in humans. Soybeans are rich in genistein, which is a phytoestrogen that binds to estrogen receptors and has an estrogenic effect. We investigated the effects of genistein administration on ITT levels, testis weight, and recovery of spermatogenesis in rats treated with a chemotherapeutic agent, busulfan. Methods: Busulfan was administered intraperitoneally to rats, and then a GnRH agonist was injected subcutaneously into the back, or genistein was administered orally. Results: The weight of the testes was significantly reduced by the treatment with busulfan. The testis weight was partially restored after busulfan treatment by additional treatment with either the GnRH agonist or genistein. Busulfan also induced atrophy of a high percentage of the seminiferous tubules, but this percentage was decreased by additional treatment with either the GnRH agonist or genistein. Treatment with genistein was effective at suppressing and maintaining ITT levels comparable to that in the GnRH agonist group. Conclusion: Genistein effectively suppressed ITT levels and stimulated the recovery of spermatogenesis in rats treated with a chemotherapeutic drug. This suggests that genistein may be a substitute for estrogens, for helping humans to recover fertility after cancer therapy without the risk of side effects.

Keywords

References

  1. Kangasniemi M, Wilson G, Huhtaniemi I, Meistrich ML. Protection against procarbazine-induced testicular damage by GnRHagonist and antiandrogen treatment in the rat. Endocrinology 1995;136:3677-80. https://doi.org/10.1210/endo.136.8.7628410
  2. Meistrich ML, Kangasniemi M. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia. J Androl 1997;18:80-7.
  3. Meistrich ML. Restoration of spermatogenesis by hormone treatment after cytotoxic therapy. Acta Paediatr Scand 1999;88:19-22.
  4. Kangasniemi M, Wilson G, Parchuri N, Huhtaniemi I, Meistrich ML. Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide). Endocrinology 1995;136:2881-8. https://doi.org/10.1210/endo.136.7.7789313
  5. Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology 2000;141:1735-45. https://doi.org/10.1210/endo.141.5.7446
  6. Shuttlesworth GA, de Rooij DG, Huhtaniemi I, Reissmann T, Russell LD, Shetty G, et al. Enhancement of a spermatogonial proliferation and differentiation in irradiated rats by GnRH antagonist administration. Endocrinology 2000;141:37-49. https://doi.org/10.1210/endo.141.1.7272
  7. Ward JA, Robinson J, Furr BJA, Shalet SM, Morris ID. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist. Cancer spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin- releasing hormone agonist. Cancer Res 1990;50:568-74.
  8. Meistrich ML, Wilson G, Kangasniemi M, Huhtaniemi I. Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after irradiation. J Androl 2000;21:464-9.
  9. Udagawa K, Ogawa T, Watanabe T, Yumura Y, Takeda M, Hosaka M. GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage. Inter J Urolo 2001;8:615-22. https://doi.org/10.1046/j.1442-2042.2001.00382.x
  10. Blanchard KT, Lee J, Boekelheide K. Leuprolide, a gonadotropinreleasing hormone agonist, reestablishes spermatogenesis after 2,5-hexanedione-induced irreversible testicular injury in the rat, resulting in normalized stem cell factor expression. Endocrinology 1998;139:236-44. https://doi.org/10.1210/endo.139.1.5678
  11. Schoenfeld HA, Hall SJ, Boekelheide K. Continuously proliferative stem germ cells partially repopulate the aged, atrophic rat testis after gonadotropin-releasing hormone agonist therapy. Biol Reprod 2001;64:1273-82. https://doi.org/10.1095/biolreprod64.4.1273
  12. Udagawa K, Takeda M, Hosaka M, Kubota Y, Ogawa T. Recovery of spermatogenesis by high dose gonadotropin-releasing hormone analogue treatment in rat cryptorchid testis after orchiopexy. J Urol 2002;168:1279-83. https://doi.org/10.1016/S0022-5347(05)64640-X
  13. Meistrich ML, Shetty G. Inhibition of spermatogonial differentiation by testosterone. J Androl 2003;24:135-48. https://doi.org/10.1002/j.1939-4640.2003.tb02652.x
  14. Meistrich ML, Wilson G, Shuttlesworth G, Huhtaniemi I, Reissmann T. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats. J Androl 2001;22:809-17.
  15. Shetty G, Weng CCY, Bolden-Tiller OU, Huhtaniemi I, Handelsman DJ, Meistrich ML. Effects of medroxyprogesterone and estradiol on the recovery of spermatogenesis in irradiated rats. Endocrinology 2004;145:4461-9. https://doi.org/10.1210/en.2004-0440
  16. Henriksson P, Carlstrom K, Pousette A, Gunnarsson PO, Johansson CJ, Eriksson B, et al. Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen. Prostate 1999;40:76-82. https://doi.org/10.1002/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q
  17. Adlercreutz H, Mazur W. Phyto-estrogens and Western diets. Ann Medici 1997;29:95-120. https://doi.org/10.3109/07853899709113696
  18. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggbald J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors $\alpha$ and $\beta$. Endocrinology 1997;138:863-70. https://doi.org/10.1210/endo.138.3.4979
  19. Setchell KDR, Cassidy A. Dietary isoflavones - biological effects and relevance to human health. J Nutri 1999;129:758S-67S.
  20. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-71. https://doi.org/10.1093/jnci/djj102
  21. Akingbemi BT, Braden TD, Kemppainen BW, Hancock KD, Sherrill JD, Cook SJ, et al. Exposure to phytoestrogens in the perinatal period affects androgen secretion by testicular Leydig cells in the adult rat. Endocrinology 2007;148:4475-88. https://doi.org/10.1210/en.2007-0327
  22. Shao ZM, Wu J, Shen ZZ, Barsky SH. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 1998;58:4851-7.
  23. Valachovicova T, Slivova V, Bergman H, Shuherk J, Sliva D. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways. Int J Oncol 2004;25:1389-95.
  24. Weber KS, Setchell KDR, Stocco DM, Lephart ED. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague- Dawley rats. J Endocrinol 2001;170:591-9. https://doi.org/10.1677/joe.0.1700591
  25. Skogseth H, Larsson E, Halgunset J. Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells. APMIS 2005;113:332-9. https://doi.org/10.1111/j.1600-0463.2005.apm_113504.x
  26. Hewitt AM, Singletary KW. Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model. Cancer Lett 2003;192:133-43. https://doi.org/10.1016/S0304-3835(02)00712-7
  27. Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, et al. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 2005;69:307-18. https://doi.org/10.1016/j.bcp.2004.09.025
  28. Farina HG, Pomies M, Alonso DF, Gomez DE. Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Reports 2006;16:885-91.
  29. McClive PJ, Sinclair AH. Type II and type IX collagen transcript isoforms are expressed during mouse testis development. Biol Reprod 2003;68:1742-7. https://doi.org/10.1095/biolreprod.102.008235
  30. Anjamrooz SH, Movahedin M, Mowla SJ, Bairanvand SP. Assessment of morphological and functional changes in the mouse testis and epididymal sperms following busulfan treatment. Iran Biomedi J 2007;11:15-22.
  31. Karashima T, Zalatnai A, Schally AV. Protective effects of analogs of luteinizing hormone releasing hormone against chemotherapy- induced testicular damage in rats. Proc Natl Acad Sci USA 1988; 85:2329-33. https://doi.org/10.1073/pnas.85.7.2329
  32. Kanatsu-Shinohara M, Toyokuni S, Morimoto T, Matsui S, Honjo T, Shinohara, T. Functional assessment of self-renewal activity of male germline stem cells following cytotoxic damage and serial transplantation. Biol Reprod 2003;68:1801-7. https://doi.org/10.1095/biolreprod.102.012575
  33. Fouchecourt S, Lareyre JJ, Chaurand P, DaGue BB, Suzuki K, Ong DE, et al. Identification, immunolocalization, regulation, and postnatal development of the lipocalin EP17 (epididymal protein of 17 kilodaltons) in the mouse and rat epididymis. Endocrinology 2003;144:887-900. https://doi.org/10.1210/en.2002-220932
  34. Adlercreutz H, Mazur W, Bartels P, Elomaa V, Watanabe S, Wahala K, et al. Phytoestrogens and prostate disease. J Nutri 2000;130: 658S-9S.
  35. Shetty G, Wilson G, Hardy MP, Niu E, Huhtaniemi I, Meistrich ML. Inhibition of recovery of spermatogenesis in irradiated rats by different androgens. Endocrinology 2002;143:3385-96. https://doi.org/10.1210/en.2002-220206
  36. Porter KL, Shetty G, Meistrich ML. Testicular edema is associated with spermatogonial arrest in irradiated rats. Endocrinology 2006; 147:1297-305. https://doi.org/10.1210/en.2005-0890
  37. Sakaue M, Ishimura R, Kurosawa S, Fukuzawa NH, Kurohmaru M, Hayashi Y, et al. Administration of estradiol-3-benzoate downregulates the expression of testicular steroidogenic enzyme genes for testosterone production in the adult rat. J Vet Med Sci 2002; 64:107-13. https://doi.org/10.1292/jvms.64.107
  38. Hossaini A, Dalgaard M, Vinggaard AM, Pakarinen P, Larsen JJ. Male reproductive effects of octylphenol and estradiol in Fischer and Wistar rats. Reprod Toxicol 2003;17:607-15. https://doi.org/10.1016/j.reprotox.2003.05.001
  39. Sharpe RM. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract Res Clin Endocrinol Metab 2006;20:91-110. https://doi.org/10.1016/j.beem.2005.09.005
  40. Brennemann W, Brensing KA, Leipner N, Boldt I, Klingmuller D. Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-tryptophan-6 luteinizing hormone releasing hormone. Clin Invest 1994;72:838-42.
  41. Kamischke A, Kuhlmann M, Weinbauer GF, Luetjens M, Yeung CH, Kronholz HL, et al. Gonadal protection from radiation by GnRH antagonist or recombinant human FSH: a controlled trial in a male nonhuman primate (Macaca fascicularis). J Endocrinol 2003; 179:183-94. https://doi.org/10.1677/joe.0.1790183

Cited by

  1. Intra-Testicular Signals Regulate Germ Cell Progression and Production of Qualitatively Mature Spermatozoa in Vertebrates vol.5, pp.None, 2013, https://doi.org/10.3389/fendo.2014.00069
  2. Genistein up-regulates miR-20a to disrupt spermatogenesis via targeting Limk1 vol.8, pp.35, 2013, https://doi.org/10.18632/oncotarget.17637
  3. The Effects of Olive Leaf Extract on The Testis, Sperm Quality and Testicular Germ Cell Apoptosis in Male Rats Exposed to Busulfan vol.13, pp.1, 2013, https://doi.org/10.22074/ijfs.2019.5520
  4. FSH and estradiol benzoate administration recover spermatogenesis and sexual hormone levels in a busulfan-injured rat model vol.29, pp.1, 2013, https://doi.org/10.1007/s00580-019-03029-3
  5. Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/3268136
  6. β-carotene Rescues Busulfan Disrupted Spermatogenesis Through Elevation in Testicular Antioxidant Capability vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.593953
  7. Genetic, biochemical and histopathological evaluations of thymoquinone on male reproduction system damaged by paclitaxel in Wistar rats vol.53, pp.10, 2013, https://doi.org/10.1111/and.14192